Association analysis between schizophrenia and the AP-3 complex genes

Neuroscience Research

Volumn 65, Issue 1, 2009, Pages 113-115

  Hashimoto, Ryota ^a,b,c   Ohi, Kazutaka ^a,c   Okada, Takeya ^b   Yasuda, Yuka ^a,c   Yamamori, Hidenaga ^a   Hori, Hiroaki ^b   Hikita, Takao ^c,d   Taya, Shinichiro ^c,d   Saitoh, Osamu ^e   Kosuga, Asako ^f   Tatsumi, Masahiko ^g   Kamijima, Kunitoshi ^f   Kaibuchi, Kozo ^c,d   Takeda, Masatoshi ^a   Kunugi, Hiroshi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Yokohama Shinryo Clinic   (Japan)

Author keywords

Adaptor protein (AP) 3 complex; AP3M1; Dysbindin; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

ADAPTOR PROTEIN; DYSBINDIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEIN COMPLEX 3; ADAPTOR PROTEIN COMPLEX MU SUBUNITS; ADULT; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 67650433833     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.05.008     Document Type: Article

References (24)

1. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., et al. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 276 (2001) 24232-24241
2. Burdick K.E., Lencz T., Funke B., Finn C.T., et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 15 (2006) 1563-1568
3. Chiba S., Hashimoto R., Hattori S., Yohda M., et al. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J. Neural Transm. 113 (2006) 1337-1346
4. Danglot L., and Galli T. What is the function of neuronal AP-3?. Biol. Cell. 99 (2007) 349-361
5. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
6. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum. Mol. Genet. 15 (2006) 3024-3033
7. Hashimoto R., Hashimoto H., Shintani N., Chiba S., et al. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol. Psychiatry 12 (2007) 1026-1032
8. Hashimoto, R., Noguchi, H., Hori, H., Ohi, K., et al., 2009. The association analysis between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects. Psychiatry Clin. Neurosci, in press.
9. Hattori S., Murotani T., Matsuzaki S., Ishizuka T., et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem. Biophys. Res. Commun. 373 (2008) 298-302
10. Iizuka Y., Sei Y., Weinberger D.R., and Straub R.E. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J. Neurosci. 27 (2007) 12390-12395
11. Kubota K., Kumamoto N., Matsuzaki S., Hashimoto R., et al. Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem. Biophys. Res. Commun. 379 (2009) 191-195
12. Kumamoto N., Matsuzaki S., Inoue K., Hattori T., et al. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem. Biophys. Res. Commun. 345 (2006) 904-909
13. Li W., Zhang Q., Oiso N., Novak E.K., et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet. 35 (2003) 84-89
14. Murotani T., Ishizuka T., Hattori S., Hashimoto R., et al. High dopamine turnover in the brains of Sandy mice. Neurosci. Lett. 421 (2007) 47-51
15. Newell-Litwa K., Seong E., Burmeister M., and Faundez V. Neuronal and non-neuronal functions of the AP-3 sorting machinery. J. Cell Sci. 120 (2007) 531-541
16. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13 (2004) 2699-2708
17. O'Donovan M.C., Craddock N., Norton N., Williams H., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40 (2008) 1053-1055
18. Scheuber A., Rudge R., Danglot L., Raposo G., et al. Loss of AP-3 function affects spontaneous and evoked release at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. USA 103 (2006) 16562-16567
19. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38 (2006) 209-213
20. Stephan K.E., Baldeweg T., and Friston K.J. Synaptic plasticity and dysconnection in schizophrenia. Biol. Psychiatry 59 (2006) 929-939
21. Takao K., Toyama K., Nakanishi K., Hattori S., et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 1 (2008) 11
22. Talbot K., Eidem W.L., Tinsley C.L., Benson M.A., et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113 (2004) 1353-1363
23. Taneichi-Kuroda S., Taya S., Hikita T., Fujinoa Y., et al. Direct interaction of Dysbindin with the AP-3 complex via its μ subunit. Neurochem. Int. 54 7 (2009) 431-438
24. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 61 (2004) 544-555